Absci Corporation (ABSI)
NASDAQ · Services · Services-commercial physical & biological research
$9.74−$0.6050 (−5.85%) on the dayAs of the close; data may be delayed.
ABSI price, last 12 months
Key stats
- Previous close
- $10.35
- Open
- $10.49
- Day range
- $9.68 – $10.50
- 52-week range
- $2.24 – $12.06
- Volume
- 3.2M
- Avg volume (20 days)
- 3.9M
- Market cap
- $1.7B
Performance
1W+0.9%
1M+5.6%
3M−10.6%
6M+238.2%
YTD+179.1%
1Y+291.2%
vs S&P 500, 1Y+274.4 pts
Technicals and fundamentals
About Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
- Sector
- Services
- Industry
- Services-commercial physical & biological research
- Listed on
- NASDAQ
- Market cap
- $1.7B